Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

por Täubel, Jörg, Hauke, Wilfried, Rump, Steffen, Viereck, Janika, Batkai, Sandor, Poetzsch, Jenny, Rode, Laura, Weigt, Henning, Genschel, Celina, Lorch, Ulrike, Theek, Carmen, Levin, Arthur A, Bauersachs, Johann, Solomon, Scott D, Thum, Thomas
Publicado 2020

A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity( )

por Lu, Dongchao, Chatterjee, Shambhabi, Xiao, Ke, Riedel, Isabelle, Huang, Cheng-Kai, Costa, Alessia, Cushman, Sarah, Neufeldt, Dimyana, Rode, Laura, Schmidt, Arne, Juchem, Malte, Leonardy, Julia, Büchler, Gwen, Blume, Jonas, Gern, Olivia-Luise, Kalinke, Ulrich, Wen Tan, Wilson Lek, Foo, Roger, Vink, Aryan, van Laake, Linda W, van der Meer, Peter, Bär, Christian, Thum, Thomas
Publicado 2022